Cerebral Chief Executive David Mou, MD, said in an Oct. 24 memo to staff that the company’s changes would be spread across all divisions, including headquarters, clinical-care teams and support staff.
Dr. Mou told employees that they would be notified over the course of the week, and a company spokesperson did not detail the precise number of jobs being cut to the Journal.
“These are challenging times for many companies,” Dr. Mou wrote in the memo. “In order to continue to work towards our mission, we have a duty to our patients to ensure our business is healthy and sustainable throughout challenging economic times.”
The layoffs come as Cerebral has been experiencing a reduction in patient appointments.
In an email sent to employees in August, Dr. Mou said the company was reducing its marketing budget and shifting funding to improve clinical quality and safety. And in July, Cerebral cut some contract workers, including nurse practitioners.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
